Pharmacogenetics of estrogen metabolism and transport in relation to cancer

Current Drug Metabolism

Volumn 4, Issue 6, 2003, Pages 505-513

  Lakhani, Nehal J ^a,b   Venitz, Jürgen ^b   Figg, William D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cancer; Estrogen; Metabolism; Pharmacogenetics; Transport

Indexed keywords

2 METHOXYESTRADIOL; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; ANTIANDROGEN; AROMATASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450; CYTOCHROME P450 17; CYTOTOXIC AGENT; DIETHYLSTILBESTROL; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; GLUCURONOSYLTRANSFERASE; GONADORELIN AGONIST; ISOENZYME; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; SULFATASE; SULFOTRANSFERASE; TAMOXIFEN; TOPOTECAN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPETITIVE INHIBITION; DEEP VEIN THROMBOSIS; DRUG RECEPTOR BINDING; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME INACTIVATION; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; FEMALE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HORMONE STRUCTURE; HORMONE SUBSTITUTION; HORMONE TRANSPORT; HUMAN; LUNG CANCER; MALE; MULTIDRUG RESISTANCE; NONHUMAN; OVARY CANCER; PHARMACOGENETICS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS;

EID: 0346147000     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200033489244     Document Type: Review

References (137)

1. Miller, J. A. (1970) Cancer Research 30, 559-576.
2. Miller, E. C. and Miller, J. A. (1981) Cancer 47(10), 2327-2345.
3. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L. and Rogan, E. G. (1997) Proc. Natl. Acad. Sci. USA 94(20), 10937-42.
4. Simpson, E. R., Clyne, C., Speed, C., Rubin, G. and Bulun, S. (2001) Ann. NY. Acad. Sci. 949(1), 58-67.
5. Nelson, L. R. and Bulun, S. E. (2001) J. Am. Acad. Dermatol. 45(3 Suppl), S116-24.
6. Dubey, R. K., Gillespie, D. G., Zacharia, L. C., Rosselli, M., Korzekwa, K. R., Fingerle, J. and Jackson, E. K. (2000) Biochem. Biophys. Res. Commun. 278(1), 27-33.
7. Simpson, E., Rubin, G., Clyne, C., Robertson, K., O'Donnell, L., Davis, S. and Jones, M. (1999) Endocr. Relat. Cancer 6(2), 131-7.
8. Grodin, J. M., Siiteri, P. K. and MacDonald, P. C. (1973) J. Clin. Endocrinol. Metab. 36(2), 207-14.
9. MacDonald, P. C., Madden, J. D., Brenner, P. F., Wilson, J. D. and Siiteri, P. K. (1979) J. Clin. Endocrinol. Metab. 49(6), 905-16.
10. Knight, D. C. and Eden, J. A. (1996) Obstet. Gynecol. 87, 897-904.
11. Boue, S., Wiese, T., Nehls, S., Burow, M., Ellliott, S., Carter-Wientjes, C., Shih, B., McLachlan, J. and Cleveland, T. (2003) J. Agric. Food Chem. 51, 2193-2199.
12. Shou, M., Korzekwa, K. R., Brooks, E. N., Krausz, K. W., Gonzalez, F. J. and Gelboin, H. V. (1997) Carcinogenesis 18(1), 207-14.
13. Aoyama, T., Korzekwa, K., Nagata, K., Gillette, J., Gelboin, H. V., and Gonzalez, F. J. (1990) Endocrinology 126(6), 3101-6.
14. Powell, W. A., Mitchell, B. F. and Challis, J. R. (1986) Gynecol. Obstet. Invest. 22(2), 64-72.
15. Kerlan, V., Dreano, Y., Bercovici, J. P., Beaune, P. H., Floch, H. H. and Berthou, F. (1992) Biochem. Pharmacol. 44(9), 1745-56.
16. Martucci, C. P. and Fishman, J. (1993) Pharmac. Ther. Vol. 57, 237-257.
17. Liehr, J. G. and Roy, D. (1990) Free Radic. Biol. Med. 8(4), 415-23.
18. Liehr, J. G. (1994) Polycyclic. Aromat. Compd. 6, 229-239.
19. Liehr, J. G., Ulubelen, A. A. and Strobel, H. W. (1986) J. Biol. Chem. 261(36), 16865-70.
20. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., Bradlow, H. L. and Fishman, J. (1982) Proc. Natl. Acad. Sci. USA 79(9), 3047-51.
21. Osborne, M. P., Karmali, R. A. and Hershcopf, R. J. (1988) Cancer Invest. 8, 629-631.
22. Adlercreutz, H., Fotsis, T., Hockerstedt, K., Hamalainen, E., Bannwart, C., Bloigu, S., Valtonen, A. and Ollus, A. (1989) J. Steroid. Biochem. 34(1-6), 527-30.
23. Milewich, L., Garcia, R. L. and Gerrity, L. W. (1984) J. Steroid. Biochem. 21(5), 529-38.
24. Spink, B. C., Katz, B. H., Hussain, M. M., Pang, S., Connor, S. P., Aldous, K. M., Gierthy, J. F. and Spink, D. C. (2000) Carcinogenesis 21(11), 1947-1957.
25. Belanger, A., Brochu, M., Lacoste, D., Noel, C., Labrie, F., Dupont, A., Cusan, L., Caron, S. and Couture, J. (1991) J. Steroid. Biochem. 40, 593-598.
26. Senafi, S. B., Clarke, D. J. and Burchell, B. (1994) Biochem. J. 303(Pt 1), 233-40.
27. Mojarrabi, B., Butler, R. and Mackenzie, P. I. (1996) Biochem. Biophys. Res. Commun. 225(3), 785-90.
28. Cheng, Z., Rios, G. R., King, C. D., Coffman, B. L., Green, M. D., Mojarrabi, B., Mackenzie, P. I. and Tephly, T. R. (1998) Toxicol. Sci. 45(1), 52-7.
29. Zhu, B. T., Evaristus, E. N., Antoniak, S. K., Sarabia, S. F., Ricci, M. J. and Liehr, J. G. (1996) Toxicol. Appl. Pharmacol. 136(1), 186-93.
30. Ball, P. and Knuppen, R. (1990) Am. J. Obstet. Gynecol. 163(6 Pt 2), 2163-70.
31. Schneider, J., Huh, M. M., Bradlow, H. L. and Fishman, J. (1984) J. Biol. Chem. 259(8), 4840-5.
32. Guldberg, H. C. and Marsden, C.A. (1975) Pharmacol. Rev. 27, 135-206.
33. Vadlamuri, S. V., Glover, D. D., Turner, T. and Sarkar, M. A. (1998) Cancer Lett. 122(1-2), 143-50.
34. Weisz, J. (1994) Polycyclic Aromat. Compd. 6, 241-251.
35. Axelrod, J. T. R. (1958) J. Biol. Chem. 233, 702-705.
36. Campbell, N. R., Dunnette, J. H., Mwaluko, G., Van Loon, J. and Weinshilboum, R. M. (1984) Clin. Pharmacol. Ther. 35(1), 55-63.
37. Lavigne, J. A., Goodman, J. E., Fonong, T., Odwin, S., He, P., Roberts, D. W. and Yager, J. D. (2001) Cancer Res. 61(20), 7488-94.
38. Lakhani, N. J., Sarkar, M. A., Venitz, J. and Figg, W. D. (2003) Pharmacotherapy 23(2), 165-172.
39. Lachman, H. M., Papolos, D. F., Saito, T. Yu, Y. M., Szumlanski, C. L. and Weinshilboum, R. M. (1996) Pharmacogenetics 6, 243-250.
40. Weinshilboum, R. M. and Raymond, F. A. (1977) Am. J. Hum. Genet. 29, 125-135.
41. Boudikova, B., Szhumlanski, C., Maidak, B. and Weinshilboum, R. (1990) Clin. Pharmacol. Ther. 48, 381-389.
42. Scanlon, P. D., Raymond, F. A. and Weinshilboum, R. M. (1979) Science 5, 63-65.
43. Worda, C., Sator, M. O., Schneeberger, C., Jantschev, T., Ferlitsch, K. and Huber, J. C. (2003) Hum. Reprod. 18(2), 262-6.
44. Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Bell, D. A., Selmin, O., Watson, M. A., Hoffman, S., Comstock, G. W. and Yager, J. D. (1997) Cancer Res. 57(24), 5493-7.
45. Thompson, P. A., Shields, P. G., Freudenheim, J. L., Stone, A., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., Kadlubar, F. F. and Ambrosone, C. B. (1998) Cancer Res. 58(10), 2107-10.
46. Hamajima, N., Matsuo, K., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Oya, H. and Obata, Y. (2001) Int. J. Clin. Oncol. 6(1), 13-8.
47. Mitrunen, K., Jourenkova, N., Kataja, V., Eskelinen, M., Kosma, V. M., Benhamou, S., Kang, D. and Vainio, H. (2001) Cancer Epidemiol. Biomarkers Prev. 10(6), 635-40.
48. Bergman-Jungestrom, M. and Wingren, S. (2001) Br. J. Cancer 85(6), 859-62.
49. Matsui, A., Ikeda, T., Enomoto, K., Nakashima, H., Omae, K., Watanabe, M., Hibi, T. and Kitajima, M. (2000) Cancer Lett. 150(1), 23-31.
50. Goodman, J. E., Lavigne, J. A., Hengstler, J. G., Tanner, B., Helzlsouer, K. J. and Yager, J. D. (2000) Cancer Epidemiol. Biomarkers Prev. 9(12), 1373-6.
51. Goodman, M. T., McDuffie, K., Kolonel, L. N., Terada, K., Donlon, T. A., Wilkens, L. R., Guo, C. and Le Marchand, L. (2001) Cancer Epidemiol. Biomarkers Prev. 10(3), 209-16.
52. Garner, E. I. O., Stokes, E. E., Berkowitz, R. S., Mok, S. C. and Cramer, D. W. (2002) Cancer Research 62, 3058-3062.
53. Huber, J. C., Schneeberger, C. and Tempfer, C. B. (2002) Maturitas 41, S55-S64.
54. Drakoulis, N., Cascorbi, I., J., B., Gross, C. R. and Roots, I. (1994) Clin. Invest. 72, 240-248.
55. Garte, S. J., Trachman, J., Crofts, F., Toniolo, P., Buxbaum, J., Bayo, S. and Taioli, E. (1996) Human Hered. 46, 121-127.
56. Hayashi, S., Watanabe, J., Nakachi, K. and Kawajiri, K. (1991) J. Biochem. 110, 407-411.
57. Crofts, F., Cosma, G., Currie, D., Taioli, E., Toniolo, P. and Garte, S. J. (1993) Carcinogenesis 14, 1729-1731.
58. Cascorbi, I., Brockmoller, J. and Roots, I. (1996) Cancer Res. 56, 4965-4969.
59. Houlston, R. S. (2000) Pharmacogenetics 10, 105-14.
60. Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H. and Alexandrov, K. (2000) Cancer Epidemiol. Biomark. Prevent. 9, 3-28.
61. Dunning, A. M., Healey, C. S., Pharoah, P. D., Teare, M. D., Ponder, B. A. and Easton, D. F. (1999) Cancer Epidemiol. Biomarkers Prev. 8(10), 843-54.
62. Taioli, E., Trachman, J., Chen, X., Toniolo, P. and Garte, S. J. (1995) Cancer Res. 55, 3757-3758.
63. Huang, Z., Fasco, M. J., Figge, H. L., Keyomarsi, K. and Kaminsky, L. S. (1996) Drug. Metab. Disp. 24(8), 899-905.
64. Liehr, J. G., Fang, W. F., Sirbasku, D. A. and Ari-Ulubelen, A. (1986) J. Steroid. Biochem. 24, 353-56.
65. Li, J. J. and Li, S. A. (1987) Fed. Proc. 46, 1858-63.
66. Han, X. and Liehr, J. G. (1995) Carcinogenesis 16, 2571-2574.
67. Stoilov, I., Akarsu, A.N., Alozie, I., Child, A., Barsoum-Homsy, M., Turacli, M.E., Or, M., Lewis, R.A., Ozdemir, N., Brice, G., Aktan, S.G., Chevrette, L., Coca-Prados, M. and Sarfarazi, M. (1998) Am. J. Hum. Genet. 62(3), 573-84.
68. Bailey, L.R., Roodi, N., Dupont ,W.D. and P. F.F. (1998) Cancer Res. 59(6), 1388.
69. Ohtake, Y., Tanino, T., Suzuki, Y., Miyata, H., Taomoto M., Azuma, N., Tanihara, H., Araie, M. and Mashima, Y. (2003) Br. J. Ophthalmol. 87(3), 302-304.
70. Hanna, I. H., Dawling, S., Roodi, N., Guengerich, F. P. and Parl, F. F. (2000) Cancer Res. 60(13), 3440-3444.
71. De Vivo, I., Hankinson, S. E., Li, L., Colditz, G. A. and Hunter, D. J. (2002) Cancer Epidemiol. Biomarkers Prev. 11(5), 489-492.
72. Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novelli, P., Franks, S. and Williamson, R. (1994) Hum. Mol. Genet. 3, 1873-1876.
73. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K. and Henderson B. E., (1997) Cancer Res. 57, 1063-1065.
74. Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z. and Henderson, B. E. (1998) Cancer Res. 58(585-587).
75. Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Comstock, G. W. and Bell, D. A. (1998) Cancer Epidemiol. Biomark. Prevent. 7, 945-949.
76. Weston, A., Pan, C.-F., Bleiweiss, I. J., Ksieski, H. B., Roy, N., Maloney, N. and Wolff, M. S. (1998) Cancer Epidemiol. Biomark. Prevent. 8, 233-239.
77. Dunning, A. M., Healey, C. S., Pharoah, P. D., Foster, N., Easton, D. F., Day, N. E. and Ponder, B. A. (1998) Br. J. Cancer 77, 2045-2047.
78. Huang, C. S., Chern, H. D., Chang, K. J., Cheng, C. W., Hsu, S. M. and Shen, C. Y. (1999) Cancer Res. 59(19), 4870-5.
79. Bergman-Jungestrom, M., Gentile, M., Lundin, A. C. and Wingren, S. (1999) Int. J. Cancer 84(350-353).
80. McKean-Cowdin, R., Feigelson, H. S., Pike, M. C., Coetzee, G. A., Kolonel, L. N. and et al, (2001) Cancer Res. 61, 848-849.
81. Ketterer, B. (1998) Mutation Res. 202, 343-361.
82. Hayes, J. D. and Pulford, D. J. (1995) Crit. Rev. Biochem. Mol. Biol. 30, 445-600.
83. Rebbeck, T. R. (1997) Cancer Epidemiol. Biomark. Prevent. 6, 733-743.
84. Hobkirk, R. (1985) Can. J. Biochem. Cell. Biol. 63, 1127-1144.
85. Miller, J. A. (1994) Drug. Metabo. Rev. 26, 1-36.
86. Hobkirk, R. (1993) Trends. Endocrinol. Metab. 4, 69-74.
87. Coughtrie, M. W., Sharp, S., Maxwell, K. and Innes, N. P. (1998) Chem. Biol. Interact. 109, 3-27.
88. Zhong, S., Wyllie, A. H., Barnes, D., Wolf, C. R. and Spurr, N. K. (1993) Carcinogenesis 14, 1821-1824.
89. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., Ford, T. D. and Shields, P. G. (1995) Cancer Res. 55, 3483-3485.
90. Kelsey, K. T., Hankinson, S. E., Colditz, G. A., Springer, K., Garcia-Closas, M., Spiegelman, D., Manson, J. E., Garland, M., Stampfer, M. J., Willet, W. C., Speizer, F. E. and Hunter, D. J. (1997) Cancer Epidemiol. Biomark. Prevent. 6, 511-515.
91. Helzlsouer, K. J., Selmin, O., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Watson, M., Comstock, G. W. and Bell, D. (1998) J. Natl. Cancer Inst. 90, 512-518.
92. Charrier, J., Maugard, C. M., Le Mevel, B. and Bignon, Y. J. (1999) Br. J. Cancer 79, 346-353.
93. Matheson, M. C., Stevenson, T., Akbarzadeh, S. and Propert, D. N. (2002) Cancer Lett. 181, 73-79.
94. Zheng, T., Holford, T. R., Zahm, S. H., Owens, P. H., Boyle, P., Zhang, Y., Zhang, B., Wise, J. P., Stephenson, L. P. and Ali-Osman, F. (2003) Br. J. Cancer 88, 58-62.
95. Sourdaine, P., Parker, M. G., Telford, J. and Miller, W. R. (1994) J. Mol. Endocrinol. 13, 331-337.
96. Miyoshi, Y., Iwao, K., Ikeda, N., Egawa, C. and Noguchi, S. (2000) Int. J. Cancer 89, 325-328.
97. Polymeropoulos, M. H., Xiao, H., Rath, D. S. and Merrill, C. R. (1991) Nucl. Acid Res. 19, 195.
98. Haiman, C. A., Hankinson, S. E., Speizer, F. E. and Hunter, D. J. (1999) Proc. Am. Assoc. Cancer Res. 40, 194.
99. Siegelmann-Danieli, N. and Buetow, K. H. (1999) Br. J. Cancer 79, 456-463.
100. Kristensen, V. N., Andersen, T. I., Lindblom, A., Erikstein, B., Magnus, P. and Borresen-Dale, A. L. (1998) Pharmacogenetics 8, 43-48.
101. Biing, J. T., Yang, Y. F., Liu, H. S., Ye, C. T. and Chao, C. F. (1994) Proc. Natl. Sci. Counc. Repub. China B. 18(2), 64-70.
102. Fujise, H., Annoura, T., Sasawatari, S., Ikeda, T. and Ueda, K. (2002) Chemosphere 46(9-10), 1505-11.
103. Leonard, G. D., Polgar, O. and Bates, S. E. (2002) Curr. Opin. Investig. Drugs 3(11), 1652-1659.
104. Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp-Helmers, M. C., Floot, B. G. and Schellens, J. H. (1999) Cancer Res. 59(18), 4559-4563.
105. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J. and Schellens, J. H. (2001) Cancer Res. 61(8), 3458-3464.
106. Kruijtzer, C. M., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M. and Schellens, J. H. (2002) J. Clin. Oncol. 20(13), 2943-2950.
107. Sugimoto, Y., Tsukahara, S., Imai, Y., Ueda, K. and Tsuruo, T. (2003) Mol. Cancer Ther. 2(1), 105-112.
108. Imai, Y., Tsukahara, S., Ishikawa, E., Tsuruo, T. and Sugimoto, Y. (2002) Jpn. J. Cancer Res. 93(3), 231-235.
109. Ee, R.P.L., Kamalakaran, S., Beck, W.T. (2003) Proceedings of the American Association for Cancer Research 44(2), 113.
110. Janvilisri, T., Venter, H., Shahi, S., Reuter, G., Balakrishnan, L., van Veen, H.W. (2003) J. Biol. Chem. 278(23), 20645-51.
111. Imai, Y., Asada, S., Tsukahara, S., Tsuruo, T., Sugimoto, Y. (2003) Proceedings of the American Association for Cancer Research 44(2), 112.
112. Iida, A., Saito, S., Sekine, A., Mishima, C., Kitamura, Y., Kondo, K., Harigae, S., Osawa, S. and Nakamura, Y. (2002) J. Hum. Genet. 47(6), 285-310.
113. Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y. and Sugimoto, Y. (2002) Mol. Cancer Ther. 1(8), 611-616.
114. Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D. and Schuetz, E. G. (2003) Pharmacogenetics 13(1), 19-28.
115. Allen, J. D., Jackson, S. C. and Schinkel, A. H. (2002) Cancer Res. 62(8), 2294-2299.
116. Honjo, Y., Hrycyna, C. A., Yan, Q.-W., Medina-Perez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. and Bates, S. E. (2001) Cancer Res. 61(18), 6635-6639.
117. Treatment and survival of patients with cancer of prostate. The Veterans Administration Cooperative Urological Research Group. (1967) Surg. Gynecol. Obstet. 124, 1011-1017.
118. Robinson, M. R., Smith, P. H., Richards, B., Newling, D. W., de Pauw, M. and Sylvester, R. (1995) Eur. Urol. 28(4), 273-283.
119. Whitesel, J. (2003) J. Urol. 169(1), 290-1.
120. Berg, F. D. and Koss, E. (1992) Arch. Gynecol. Obstet. 251, 17-27.
121. Seegers, J. C., Lottering, M. L., Grobler, C. J., van Papendorp, D. H., Habbersett, R. C., Shou, Y. and Lehnert, B. E. (1997) J. Steroid. Biochem. Mol. Biol. 62(4), 253-67.
122. Mukhopadhyay, T. and Roth, J. A. (1997) Oncogene 14(3), 379-84.
123. Schumacher, G., Kataoka, M., Roth, J. A. and Mukhopadhyay, T. (1999) Clin. Cancer Res. 5(3), 493-9.
124. La Valee, T.M., Zhan, X.H., Herbstritt, C.J., Johnson, M.S., Williams, M.S., Hembrough, W.A., Green, S.J., Pribluda, V.S. (2002) Proceeding of the American Association for Cancer Research 43, 703.
125. Klauber, N., Parangi, S., Flynn, E., Hamel, E. and D'Amato, R. J. (1997) Cancer Res. 57(1), 81-6.
126. Yue, T. L., Wang, X., Louden, C. S., Gupta, S., Pillarisetti, K., Gu, J. L., Hart, T. K., Lysko, P. G. and Feuerstein, G. Z. (1997) Mol. Pharmacol. 51(6), 951-62.
127. D'Amato, R. J., Lin, C. M., Flynn, E., Folkman, J. and Hamel, E. (1994) Proc. Natl. Acad. Sci. USA 91(9), 3964-8.
128. LaVallee, T. M., Zhan, X. H., Herbstritt, C. J., Kough, E. C., Green, S. J. and Pribluda, V. S. (2002) Cancer Res. 62(13), 3691-7.
129. Miller, K.D., Murry, D.J., Curry, E., Haney, L.G., McClaskey, N., Storniolo, A.M., Philips, E., Pribluda, V., Gubish, E.R., Sledge, G.W. (2002) Proceedings of The American Society of Clinical Oncology 21, 111a.
130. Sledge, G.W., Miller, K.D., Haney, L.G., Nguyen, D.D., Storniolo, A.M., Phillips, E.N., Pribluda, V., Gubish, E.R. (2002) Proceedings of The American Society of Clinical Oncology 21, 111a.
131. Miller, K.D., Haney, L.G., Pribluda, V.S., Sledge, G.W. (2001) Proceedings of The American Society of Clinical Oncology 20, 43a.
132. Jernstrom, H., Chu, W., Vesprini, D., Tao, Y., Majeed, N., Deal, C., Pollack, M. and Narod, S. A. (2001) Mol. Genet. Metab. 72(2), 144-54.
133. Kristensen, V. N. and Borresen-Dale, A. L. (2000) Mutat. Res. 462(2-3), 323-33.
134. Guillemette, C., De Vivo, I., Hankinson, S. E., Haiman, C. A., Spiegelman, D., Housman, D. E. and Hunter, D. J. (2001) Cancer Epidemiol. Biomarkers Prev. 10(6), 711-714.
135. Adjei, A.A., Thomae, B.A., Prondzinski, J.L., Eckloff, B.W., Wieben, E.D. and Weinshilboum, R.M. (2003) Br. J. Pharmacol. 139(8), 1373-82.
136. Sparreboom, A., de Jonge, M. J. and Verweij, J. (2002) Eur. J. Cancer 38(1), 18-22.
137. Sparreboom, A., Danesi, R., Ando, Y., Chan, J. and Figg, W. D. (2003) Drug Resistance Updates 266, 71-84.